Ipilimumab (Drug)

Ipilimumab Side Effect Management in Melanoma

Immunotherapy: Yervoy and Beyond

Cancer Immunotherapy with Nivolumab Plus Ipilimumab Vs. Chemotherapy: Insights from CheckMate 227

Dr. Hoos Talks About a Possible Successor Drug to Ipilimumab

Combination Immunotherapy Animation

Random42 Scientific Communication

Dana Monroe Discusses Ipilimumab's Side Effects

Dr. Schuchter Discusses Managing Ipilimumab's Side Effects

History of Melanoma Immunotherapy - From Freund to Ipilimumab

Success for ipilimumab and nivolumab combo in advanced melanoma

Dr. Sharpless on Managing Toxicities With Nivolumab/Ipilimumab in Melanoma

Adjuvant Treatment Selection in High-Risk Melanoma

Ipilimumab Ten Year Anniversary with Sharon Belvin

Cancer Research Institute

Dr. Sosman on the Mechanism of Action of Ipilimumab in Melanoma

Advanced Melanoma

Nivolumab + ipilimumab superior to ipilimumab alone for advanced melanoma

Complications of Immunotherapy

Dr. Sznol Discusses the Combination of Ipilimumab and Nivolumab in Melanoma

Novel Immunotherapies and Combinations

GRACE - Global Resource for Advancing Cancer Education

Debate: Targeting the immune system with checkpoint inhibitors - Single drug therapy

Benefits and risks of reinduction ipilimumab/nivolumab in patients with melanoma